Member Info for Toukankahmoon

US stockbrokers closed tomorrow and Friday. Don’t know how many Americans have UK stockbrokers?

Codejunkie
Thanks for sharing a fact that probably is contributing to keeping SP down

Good find Rippers thanks for posting and follow ups from Jive, etc. It is frustrating but sums up the predicament. Just have to wait for the RNS that “blows the bl**dy doors off” to misquote a phrase.

Stand easy. It’s a vaccine

Hanoi
Please post link to this:
“ But Avacta are one of the Marsden's lead P1 programs,”

I missed it
Thanks

The support of Avacta is a religion. No heretical views will be tolerated.
GLA

It’s what keeps me feeling young Rippers

Think what I’ll be able to do when we are all millionaires

Aaah is it raining too much for the poor diddums to go out and play Bob the builder.

Strange
Charting isn’t about “high frequency trading”

Buen
More effective
Less destructive
Affordable

There are competitive treatments going through R&D which could be very effective treatments. The first to market will be difficult to dislodge.

The question that haunts us all on here (and don’t say it doesn’t because post after post tries to answer the question or reels off all the good reasons why Avacta is such a good investment) is WHY IS THE SP SO LOW?
So Bue, why do you think it’s so low:
- Institutions can’t see true value
- MMS manipulating us
- at least 2 years before Avacta provides a dividend
- large investors in this sector are well aware of the competition and aren’t just blinkered to Avacta
- everything’s covered by NDAs so they can’t let the cat out of the bag
- there is a lack of trust in BoD after Affidx fiasco

Or pick one of your own.

None of the above means it doesn’t work. And when we get the RNS I will be cheering as loud as anyone. Anyone that is other than the cancer patients that will benefit not just from AVA6000 but from the great treatments to follow.

Comparing Avacta to Avacta double amazing

Buen
Do you know why the UK market was flooded with Chinese LFTs and a year later when the best test in the world was ready for market it didn’t get a look in ???

Jeez let’s hope we get the RNS to say it works soon so we can all get back to doing what we used to do before this all started.

This is a great BB for working hard to misconstrue what people are saying just to have an abusive go at them.

Further back in this thread someone pointed out that Ava6000has competition out there. Someone else said but if they beat us to market don’t worry because when AVA6000 comes on the market it will be so superior it will take the whole market.

I just said that history shows that that doesn’t always happen and there is no room for complacency.

Rippers you know damn well I’m not advocating taking dangerous short cuts. But I am saying that the process to get this to market and the marketing need to be as quick and effective as possible and I’m not sure that Avacta have demonstrated those characteristics so far.
It may be because this is new to them and they have underestimated the timescales but that isn’t much comfort.

My take from this is that there needs to be some urgency. I don’t agree with the “no news is good news” view.

And how many times has an inferior product been first to market and established itself and the Johnny come lately superior product hasn’t got a look in.

Come on Avacta get a wiggle on.

Oh well that’s a 95p close tomorrow the n

Riesgo
I think you mean end of Feb 24 if you’re talking about RAH’s figures. Yes there’ll be the odd £10M along the way in fees etc
But no rush to get invested yet, we’ll at least not until ??

Rippers
You can be a nasty abusive b*stard and Uber ramp on a rumour.
But for some reason I actually believe you.
Thanks for posting and a down to earth reminder that for so many people this is going to be far more important than money.
GLA

Thank you those who haven’t felt the need to descend into abuse. Abuse is unnecessary and shows you up for what you are.

I do believe that AVA6000 works in humans. But there is a chance that (because we are humans not mice) that it just isn’t delivering the expected amount of dox to the tumour and that is why the trial might need to go another round.

I find it hard to believe that we PIs are the only ones that can see the potential of AVA6000. So why aren’t big pharma and investment and pension funds buying in at this point. Surely they must have better knowledge and experience of these opportunities than we do. It doesn’t make sense and when that’s the case there are usually good reasons.

And while I’m at it. I really cannot see an order of magnitude jump in SP when the good news comes unless there is takeover talk because it will be at least a couple of years before we see a dividend.

Avacta we’re pretty quick to RNS that Fiona wasn’t going to provide an update at that conference a few weeks back.

My worst scenario (and I pray it doesn’t happen) is that next RNS is great news for diagnostics divn followed a couple days later by RNS telling the real AVA6000 story.

GLA